This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.
Adult patients (male or female), aged 18 years or older
Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days
Equipped with an arterial catheter for invasive blood pressure monitoring
Equipped with a urinary catheter for invasive core body temperature monitoring
Patients under 18 years old (minors)
Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use
History of extensive skin pathology (e.g., Lyell syndrome)
Patients with therapeutic limitations
Single group
MultiSense® Non-Invasive Hemodynamic Monitoring Device
DeviceThe MultiSense® device is a wireless, non-invasive monitoring system designed to continuously measure blood pressure, microcirculation, central body temperature, and detect arrhythmias in ICU patients. It aims to reduce risks associated with invasive monitoring, improve patient comfort and mobility, and decrease alarm fatigue through intelligent alert algorithms.
Primary outcome: Agreement between non-invasive blood pressure index (IPA) from MultiSense® and invasive blood pressure (PAI) from ICU monitors.
Click on the lead sponsor to view all of their trials.
